In contrast with the FLOW-AF protocol requiring the randomization of source patients to PVI-only or PVI + EGF-guided ablation of sources, the AF-FLOW Global Registry patients predominantly received PVI plus targeted adjunctive source ablation when sources were observed. Here, EGF is linked to atrial fibrillation.